|
Actavis is Icelandic for generic. Iceland-based Actavis Group is one of the world's largest generic pharmaceuticals producers. The company has about 350 drugs in its development pipeline, and nearly 1,000 products on the market across a variety of therapeutic classes (among them cardiovascular, gastrointestinal, and oncology). It also manufactures generic hospital products, including antibiotics, anesthetics, and painkillers. Actavis makes drugs in pill, injectable, suppository, and other forms. Subsidiary Medis distributes its drugs worldwide. Actavis, which was founded in 1956, is controlled by chairman Thor Bjorgolfsson through his investment vehicle Novator. At the company's helm is CEO Sigurdur Oli Olafsson.
|
| | | Contact Information | |
Address: |
Dalshrauni 1
220 Hafnarfirdi, Iceland
| | Phone: | +354-535-2300 | | Fax: | +354-535-2301 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 2329.40 M | | Employees (2008): | 530 |
|
|
Key People
| | • |
Chairman:
Thor Bjorgolfsson
| | • |
CEO and Director:
Sigurdur Oli Olafsson
| | • |
Deputy CEO:
Gudbjorg Edda Eggertsdottir
|
|
|
